Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer-Reference-Cited by-同舟云学术

Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer

Published:2018-04-15 Issue:2 Volume:26 Page:244-249
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Wang Yi-Lun¹,Peng Hsiu-Huei²,Su Sheng-Yuan²,Lin Cheng-Tao²³⁴

Affiliation:

1. Chang Gung University College of Medicine and Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan

2. Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Linkou Medical Center, Taoyuan, Taiwan

3. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Linkou Medical Center, Taoyuan, Taiwan

4. Chang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Linkou Medical Center, Taoyuan, Taiwan

Funder

Chang Gung University Hospital

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719118768684

Reference33 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

2. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

3. Ovarian cancer

4. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions;Cell & Bioscience;2024-02-17

2. The potential role of interleukins and interferons in ovarian cancer;Cytokine;2023-11

3. Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery;Frontiers in Oncology;2023-07-31

4. Increased absolute lymphocyte count, increased absolute neutrophil count and low platelet to lymphocyte ratio as predicting factors in the superior disease control of refractory/relapsing gynecologic malignancies with anti PD-1 therapy: 10 years of experience in a single institution;Taiwanese Journal of Obstetrics and Gynecology;2023-07

5. Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy;Frontiers in Immunology;2022-12-01